Sonitor Introduces SonitorBLU™ and SonitorMOBILE™
17.4.2023 19:35:00 EEST | Business Wire | Press release
Sonitor® Technologies today announced expansion of its market leading Sense™ platform with SonitorBLU, a proprietary Bluetooth Low Energy (BLE) solution for use cases when zonal accuracy is required, and SonitorMOBILE, a location visibility platform for positioning smart devices, combining Sonitor’s ultrasound technology with BLE to provide best-in-class accuracy, effectively turning a smart phone into an RTLS tag. The company made the announcement at the HIMSS Global Health Conference where it is exhibiting from April 18-20.
Sonitor’s new portfolio offers a tiered approach to the challenges faced by healthcare providers. These range from simple asset tracking to more demanding applications that require speed and accuracy such as patient flow and clinical workflow, as well as the critical need to ensure staff safety. As with Sense, these new products offer advanced analytics for workflow insights, and appropriate staffing assignments that help increase hospital capacity and improve patient and staff satisfaction.
“Sonitor is excited to invite healthcare providers, technology partners and all HIMSS attendees to our booth where we will be showcasing the SonitorBLU, Sonitor Sense and SonitorMOBILE suite of products,” said Matt Crane, Chief Commercial Officer, North America/CEO, Sonitor Inc. “In addition, we have recently expanded our team of clinical and technology experts to customize Sonitor’s solutions to meet customers’ strategic objectives and budgets.”
With SonitorBLU, hospitals have an easy-to-install platform to address use cases such as asset tracking when near real-time data flow is sufficient. With no cabling, installation is simple and fast, and the system can be up and reporting locations in less than a day. SonitorMOBILE, combines Sonitor’s patented ultrasound technology, SonitorULE™, and BLE to provide centimeter level accuracy with refresh rates of 1-2 seconds, to “move at the speed of a nurse™,” for highly demanding use cases.
About Sonitor
Sonitor Technologies AS is the leading provider of accurate, affordable, and easy to use Real Time Locating Systems (RTLS) with wearables for staff safety and workforce enablement. The first and only company to commercialize low energy ultrasound as the primary locating technology with proven 99.9% location accuracy, SonitorULE™, is more affordable than traditional RTLS platforms using radio (RF or RFID) or infrared (IR) technologies. Based on its proven record for uptime performance in clinical settings, Sonitor is the only RTLS company to offer a 5-year warranty as standard on its infrastructure technology. The company received a high ranking in the 2023 Best in KLAS RTLS report, second only to the winner, Sonitor partner Securitas Healthcare. Sonitor also earned certification as a “Great Place to Work®” in 2022 and was recognized as among the top companies poised for growth based on innovation and customer alignment in Frost & Sullivan’s Radar™ Industry Report for Indoor Positioning Systems (IPS). To learn more visit www.sonitor.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230417005644/en/
Contact information
Dan Conley
Beacon Communications dconley@beaconpr.com
+1-312-593-8461
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Dream Accelerates Growth of Asset Management Platform With Acquisition of Chancerygate, a Leading U.K.-Based Industrial Asset Manager and Developer31.7.2026 01:09:00 EEST | Press release
Dream Unlimited Corp. (“Dream”) (TSX: DRM) today announced that Dream and Dream Industrial Real Estate Investment Trust (“Dream Industrial REIT”) (TSX: DIR.UN), have entered into definitive agreements for Dream to acquire Chancerygate Limited (“Chancerygate” or “CG”), a U.K.-based industrial developer and asset manager with a 30-year track record in the multi-let industrial (“MLI”) sector. Chancerygate currently manages a diversified portfolio of income producing and development assets totaling £1.2 billion ($2.2 billion). As part of the transaction, Dream will assume Chancerygate's investment management and development platform. Dream Industrial REIT will acquire Chancerygate's wholly owned real estate assets and co-investment interests across its managed ventures for consideration of approximately £78 million ($147 million), gross of certain in-place debt, and expects to fund an additional £25 million ($47 million) to complete the wholly owned development projects. The transactions a
Dream Industrial REIT Announces Entry Into U.K. Multi-Let Industrial Market and Growth of Strategic Private Ventures in Europe31.7.2026 01:06:00 EEST | Press release
Dream Industrial Real Estate Investment Trust (TSX: DIR.UN) (the “Trust” or the “REIT” or “DIR”) today announced that the Trust and Dream Unlimited Corp. (TSX: DRM) (“Dream”), have entered into definitive agreements for Dream to acquire Chancerygate Limited (“Chancerygate” or “CG”), a U.K.-based industrial developer and asset manager with a 30-year track record in the multi-let industrial (“MLI”) sector. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260730297448/en/ Audio Park, Sussex, UK - 104,000 sq ft As part of the transaction, Dream will assume Chancerygate's investment management and development platform. Dream Industrial REIT will acquire Chancerygate's wholly owned real estate assets and co-investment interests across its managed ventures for consideration of approximately £78 million ($147 million), gross of certain in-place debt on the wholly owned real estate assets, and expects to fund an additional £25 million
Rimini Street Announces Fiscal Second Quarter 2026 Financial and Operating Results30.7.2026 23:03:00 EEST | Press release
Rimini Street, Inc., (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, managed services and Agentic AI ERP innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced results for the fiscal second quarter ended June 30, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260730702735/en/ Rimini Street Announces Fiscal Second Quarter 2026 Financial and Operating Results “Second-quarter results and four consecutive quarters of improved growth metrics demonstrate strong demand for our core Rimini Support™ offering, increasing adoption of our broader enterprise software services portfolio and improving sales execution,” said Seth Ravin, president and CEO, Rimini Street. “Real innovation is not about installing a software vendor’s next ‘.ai’ release — it is about reducing total operating costs, improving profitability and enhancing competitive
Rimini Street Launches Rimini Govern™ for AI to Deliver Comprehensive AI Agent Governance, Security & Interoperability as a Service30.7.2026 23:01:00 EEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced the immediate availability of Rimini Govern™ for AI, the newest offering in the company’s Rimini Govern portfolio of Governance, Risk and Compliance (GRC) solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260730389723/en/ Rimini Street Launches Rimini Govern™ for AI to Deliver Comprehensive AI Agent Governance, Security & Interoperability as a Service The new managed service is delivered 24/7/365 through Rimini Street’s Global Command Centers by expert AI engineers to help organizations: Accelerate AI agent deployment Reduce AI agent operational risk Increase visibility into AI agent activity Provide AI agent activity audit capability Control AI agent operating costs Measure business value from AI agent investments Scale AI agent adoptio
One Biosciences Announces Data Validating New Method for Single-Cell Transcriptomic Tumor Profiling from Clinical Pathology Samples30.7.2026 22:03:00 EEST | Press release
One Biosciences, a techbio company pioneering clinical-grade single-cell tumor profiling, today announced data establishing that single-cell RNA expression profiles can be generated from the standard, formalin-fixed paraffin-embedded (FFPE) pathology specimens obtained in routine cancer care using the company’s proprietary platform, OneMap™. The study, conducted with collaborators at Centre Léon Bérard, Hôpital Bichat–Claude Bernard, Institut Curie, and Memorial Sloan Kettering Cancer Center, was released as a preprint on BiorXiv. “Every tumor is a unique ecosystem of many different types of cells, some cancerous, some not. Single cell profiling enables us to understand what those cells are, what they’re doing and potentially how that may impact treatment outcomes,” said Helena Yu, MD, thoracic medical oncologist at Memorial Sloan Kettering Cancer Center. “Until now that type of analysis required different types of samples and workflows than we deploy in clinical care. This study shows
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom